Stance Capital’s Clorox CLX Stock Holding History

Stance Capital’s Portfolio CLX Stock Details CLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-12,989	Closed	-$1.56M	–	285
2025 Q2	$1.56M	Buy	+12,989	New	+$1.73M	0.59%	52
2025 Q1	–	Sell	-4	Closed	-$650	–	95
2024 Q4	$650	Buy	+4	New	+$654	﹤0.01%	236

Other funds holding CLX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Stance Capital's CLX Position: Q3 2025 in Review

Stance Capital sold out of Clorox (CLX) in Q3 2025, closing a stake of 12,989 shares — an estimated $1.56M sold.

Stance Capital first reported a position in CLX in Q4 2024 and held it in 2 quarters. The position peaked at $1.56M in Q2 2025. 1,091 funds tracked by Wall St. Rank hold CLX as of Q3 2025.

Stance Capital reported no remaining Clorox position as of Q3 2025 after selling out during the quarter.
Stance Capital sold 12,989 Clorox shares in Q3 2025, an estimated $1.56M.
Stance Capital first reported a position in Clorox in Q4 2024 and held it in 2 quarters.
Stance Capital's Clorox position peaked at $1.56M in Q2 2025.
1,091 funds tracked by Wall St. Rank held Clorox as of Q3 2025.

Based on Stance Capital's 13F filing for Q3 2025, filed 19 Nov 2025.